Comparative Analysis of the Effectiveness of Methotrexate Co-Administration with Baricitinib in Rheumatoid Arthritis Treatment

OBJECTIVES: To evaluate the effect of methotrexate (MTX) co-administration with baricitinib (BAR) in rheumatoid arthritis (RA) treatment using a multicenter registry. METHODS: A total of 296 patients with RA treated with BAR were included (167 with MTX and 129 without MTX). Treatment effectiveness over 52 weeks was evaluated using propensity score-based overlap weighting to adjust for baseline differences. Group-based trajectory modeling (GBTM) was applied to identify distinct longitudinal response patterns. RESULTS: After overlap weighting, baseline characteristics were successfully balanced between groups (standardized mean differences <0.1). No significant differences were observed between the -MTX and +MTX groups in treatment retention (76.3% vs. 83.7%, p=0.213), CDAI scores at week 52 (5.7 [95% CI 4.2-7.1] vs. 5.8 [95% CI 4.5-7.1], p=0.90), or remission rates (32.1% vs. 34.5%, p=0.70). GBTM identified four distinct trajectories of disease activity; however, the distribution of MTX use did not differ across trajectory groups. CONCLUSIONS: After adjustment for baseline differences, MTX co-administration was not associated with improved clinical outcomes or response trajectories during BAR therapy. These findings may inform treatment decisions for patients unable to receive concomitant MTX.

Authors

Institutions

Publication Details

Journal
Modern Rheumatology
Published
2026-11-18
DOI
https://doi.org/10.1093/mr/roag099
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Comparative Analysis of the Effectiveness of Methotrexate Co-Administration with Baricitinib in Rheumatoid Arthritis Treatment

Shiro Imagama, Nobunori Takahashi, Yuji Hirano, Tomonori Kobayakawa et al.
Modern Rheumatology
Rheumatoid Arthritis Research and Therapies
article

Comparative Analysis of the Effectiveness of Methotrexate Co-Administration with Baricitinib in Rheumatoid Arthritis Treatment

Shiro Imagama, Nobunori Takahashi, Yuji Hirano, Tomonori Kobayakawa, Tsuyoshi Watanabe, Toki Takemoto, Toshihisa Kojima, Yutaka Yoshioka, Yasumori Sobue, Tsuyoshi Nishiume, Masahiro Hanabayashi, Kenya Terabe, Shuji Asai, Mihoko Kato, Yasuhide Kanayama, Takefumi Kato, Takayoshi Fujibayashi, Hiroyuki Matsubara, Mochihito Suzuki, Tatsuo Watanabe
article en

Abstract

OBJECTIVES: To evaluate the effect of methotrexate (MTX) co-administration with baricitinib (BAR) in rheumatoid arthritis (RA) treatment using a multicenter registry. METHODS: A total of 296 patients with RA treated with BAR were included (167 with MTX and 129 without MTX). Treatment effectiveness over 52 weeks was evaluated using propensity score-based overlap weighting to adjust for baseline differences. Group-based trajectory modeling (GBTM) was applied to identify distinct longitudinal response patterns. RESULTS: After overlap weighting, baseline characteristics were successfully balanced between groups (standardized mean differences <0.1). No significant differences were observed between the -MTX and +MTX groups in treatment retention (76.3% vs. 83.7%, p=0.213), CDAI scores at week 52 (5.7 [95% CI 4.2-7.1] vs. 5.8 [95% CI 4.5-7.1], p=0.90), or remission rates (32.1% vs. 34.5%, p=0.70). GBTM identified four distinct trajectories of disease activity; however, the distribution of MTX use did not differ across trajectory groups. CONCLUSIONS: After adjustment for baseline differences, MTX co-administration was not associated with improved clinical outcomes or response trajectories during BAR therapy. These findings may inform treatment decisions for patients unable to receive concomitant MTX.

Modern Rheumatology
Aichi Medical University (JP), Konan Kosei Hospital (JP), Aichi Medical University Hospital (JP), Hekinan Technical High School (JP), Ichinomiya Municipal City Hospital (JP), Okazaki City Hospital (JP), Shizuoka City Hospital (JP), Japanese Red Cross Nagoya Daiichi Hospital (JP), Shizuoka General Hospital (JP), National Hospital Organization (JP), Toyota Kosei Hospital (JP), Anjo Kosei Hospital (JP), Toyohashi Municipal Hospital (JP), Nagoya Medical Center (JP), National Center for Geriatrics and Gerontology (JP), Daido Hospital (JP), Hekinan Municipal Hospital (JP), National Hospital for Geriatric Medicine, National Center for Geriatrics and Gerontology (JP), Daido University (JP), Nagoya University (JP)
Good health and well-being
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon